首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways
【2h】

Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways

机译:miR-34c的过表达通过靶向Notch信号通路抑制高糖诱导的足细胞凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent findings have shown that microRNAs play critical roles in the pathogenesis of diabetic nephropathy. miR-34c has been found to inhibit fibrosis and the epithelial-mesenchymal transition of kidney cells. However, the role of miR-34c in diabetic nephropathy has not been well studied. The current study was designed to investigate the role and potential underlying mechanism of miR-34c in regulating diabetic nephropathy. After treating podocytes with high glucose (HG) in vitro, we found that miR-34c was downregulated and that overexpression of miR-34c inhibited HG-induced podocyte apoptosis. The direct interaction between miR-34c and the 3’-untranslated region (UTR) of Notch1 and Jagged1 was validated by dual-luciferase reporter assay. Moreover, Notch1 and Jagged1 as putative targets of miR-34c were downregulated by miR-34c overexpression in HG-treated podocytes. Overexpression of miR-34c inhibited HG-induced Notch signaling pathway activation, as indicated by decreased expression of the Notch intracellular domain (NICD) and downstream genes including Hes1 and Hey1. Furthermore, miR-34c overexpression increased the expression of the anti-apoptotic gene Bcl-2, and decreased the expression of the pro-apoptotic protein Bax and cleaved Caspase-3. Additionally, the phosphorylation of p53 was also downregulated by miR-34c overexpression. Taken together, our findings suggest that miR-34c overexpression inhibits the Notch signaling pathway by targeting Notch1 and Jaggged1 in HG-treated podocytes, representing a novel and potential therapeutic target for the treatment of diabetic nephropathy.
机译:最近的发现表明,微小RNA在糖尿病性肾病的发病机理中起关键作用。已发现miR-34c抑制肾细胞的纤维化和上皮-间质转化。但是,miR-34c在糖尿病肾病中的作用尚未得到很好的研究。本研究旨在研究miR-34c在调节糖尿病性肾病中的作用和潜在的潜在机制。在体外用高葡萄糖(HG)处理足细胞后,我们发现miR-34c被下调,而miR-34c的过表达抑制HG诱导的足细胞凋亡。 miR-34c与Notch1和Jagged1的3'-非翻译区(UTR)之间的直接相互作用已通过双荧光素酶报告基因检测验证。此外,miR-34c在HG处理的足细胞中的过表达下调了Notch1和Jagged1作为miR-34c的推定靶标。 miR-34c的过表达抑制了HG诱导的Notch信号通路的激活,如Notch细胞内域(NICD)和下游基因(包括Hes1和Hey1)的表达降低所表明的。此外,miR-34c的过表达增加了抗凋亡基因Bcl-2的表达,并降低了促凋亡蛋白Bax和Caspase-3的表达。另外,miR-34c过表达也下调了p53的磷酸化。综上所述,我们的发现表明,miR-34c过表达通过靶向HG治疗的足细胞中的Notch1和Jaggged1来抑制Notch信号传导途径,代表了治疗糖尿病性肾病的一种新型且潜在的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号